Study Objectives: Postoperative respiratory complications (PRCs) are common among children with obstructive sleep apnea (OSA) after adenotonsillectomy. We analyzed postoperative admission guidelines to determine which optimally balanced patient safety and cost.

Methods: Retrospective study of children aged 12 years or younger undergoing adenotonsillectomy for OSA after polysomnography at a tertiary academic care center over 2 years. Demographics, medical History, and hospital course were collected. Advanced Excel modeling was used to assess the number of children with PRCs identified with guideline admission criteria and to validate the significance of these findings in our patient population with logistic regression.

Results: Six hundred thirty children were included; 116 had documented PRCs. Children with PRCs were younger ( = .024) and more frequently male ( = .012). There were no significant differences in race ( = .411) or obesity ( = .265). More children with PRCs had an apnea-hypopnea index (AHI) > 24 events/h ( < .001). Following guidelines from the American Academy of Pediatrics, American Academy of Otolaryngology - Head and Neck Surgery, and Nationwide Children's Hospital, 82%, 87%, and 99% of children with PRCs would be identified, costing $535,962, $647,165, and $1,053,694 for admission, respectively. Using a non-validated, forced model to refine predictors described in published guidelines, our model would have identified 95% of children with one or more PRCs, with a moderate cost.

Conclusions: Current admission guidelines attempt to identify children with OSA at high risk for PRCs after adenotonsillectomy; however, none consider the economic cost to the health care system. We present a comparison of the number of patients identified with PRCs after adenotonsillectomy and the cost of expected admissions using currently published guidelines.

Commentary: A commentary on this article appears in this issue on page 1371.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695994PMC
http://dx.doi.org/10.5664/jcsm.6850DOI Listing

Publication Analysis

Top Keywords

children prcs
20
children
10
prcs
9
admission criteria
8
children obstructive
8
obstructive sleep
8
sleep apnea
8
admission guidelines
8
prcs identified
8
american academy
8

Similar Publications

The generation of induced pluripotent stem cells (iPSCs) from differentiated somatic cells by Yamanaka factors, including pioneer transcription factors (TFs), has greatly reshaped our traditional understanding of cell plasticity and demonstrated the remarkable potential of pioneer TFs. In addition to iPSC reprogramming, pioneer TFs are pivotal in direct reprogramming or transdifferentiation where somatic cells are converted into different cell types without passing through a pluripotent state. Pioneer TFs initiate a reprogramming process through chromatin opening, thereby establishing competence for new gene regulatory programs.

View Article and Find Full Text PDF

Background And Objective: Despite significant advancements in the safe delivery of anesthesia and improvements in surgical techniques, postoperative respiratory complications (PRCs) remain a serious concern. PRCs can lead to increased length of hospital stay, worsened patient outcomes, and higher hospital and postoperative costs. Perioperative lung injury and PRCs are more common in children than in adults owing to children's unique physiology and anatomical characteristics.

View Article and Find Full Text PDF

Background: Global initiatives have been put in place to attain a thorough understanding of worldwide variations in physical activity (PA) among children and adolescents. Yet, there is limited knowledge about PA-related indicators, specifically for children and adolescents with disabilities (CAWD). To bridge this data gap, the Global Matrix of Para Report Cards (PRCs) of CAWD initiative was established to address the scarcity of information on PA for this population globally.

View Article and Find Full Text PDF

Modeling high-risk Wilms tumors enables the discovery of therapeutic vulnerability.

Cell Rep Med

October 2024

McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53706, USA; Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI 53706, USA. Electronic address:

Article Synopsis
  • Wilms tumor (WT) is the most common kidney cancer in children, but a less-differentiated form often comes back after treatment, prompting the need for better therapies.
  • Researchers created a modified version of a WT cell line (WiT49) that can form tumors and spread, allowing them to study the aggressive type of WT in mice.
  • Drug testing revealed that certain medications, especially histone deacetylase (HDAC) inhibitors, are effective against this aggressive WT, offering a potential new treatment avenue for high-risk patients.
View Article and Find Full Text PDF

Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders.

Genet Med

September 2024

Department of Neuromuscular Diseases, University College London, Queen Square, Institute of Neurology, WC1N 3BG London, UK. Electronic address:

Purpose: This study aims to comprehensively delineate the phenotypic spectrum of ACTL6B-related disorders, previously associated with both autosomal recessive and autosomal dominant neurodevelopmental disorders. Molecularly, the role of the nucleolar protein ACTL6B in contributing to the disease has remained unclear.

Methods: We identified 105 affected individuals, including 39 previously reported cases, and systematically analysed detailed clinical and genetic data for all individuals.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!